In the latest stock market update, JP Morgan analyst Lisa Gill has maintained her "Overweight" rating on Privia Health Group (PRVA, Financial) while raising the price target from $29.00 to $32.00. This adjustment signifies a notable 10.34% increase in the target price, reflecting a positive outlook on the stock's potential.
The updated price target of $32.00 suggests that the analyst sees further upside for Privia Health Group (PRVA, Financial), bolstering investor confidence in the company's future performance. The "Overweight" rating indicates that the analyst expects the stock to outperform other stocks in the same sector over the coming months.
Investors should consider the implications of this rating and target adjustment as they make decisions regarding their positions in Privia Health Group (PRVA, Financial). The information may also serve as a reference point for evaluating the stock's valuation and prospects in the healthcare sector.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 20 analysts, the average target price for Privia Health Group Inc (PRVA, Financial) is $30.60 with a high estimate of $37.00 and a low estimate of $24.00. The average target implies an upside of 32.84% from the current price of $23.04. More detailed estimate data can be found on the Privia Health Group Inc (PRVA) Forecast page.
Based on the consensus recommendation from 22 brokerage firms, Privia Health Group Inc's (PRVA, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Privia Health Group Inc (PRVA, Financial) in one year is $47.91, suggesting a upside of 107.99% from the current price of $23.035. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Privia Health Group Inc (PRVA) Summary page.